For citations:
Meltonian AR, Laevskaya MY, Savchenkov YN, Babenko AY. Thioredoxin-interacting protein TXNIP as a promising diagnostic marker for metabolic-associated fatty liver disease in patients with type 2 diabetes. Meditsinskiy sovet = Medical Council. 2024;(23):137-143. (In Russ.) https://doi.org/10.21518/ms2024-532